No commercial support was received for this learning activity.
Magnesium Sulfate During Anticipated Preterm Birth for Infant Neuroprotection
Article first published online: 11 FEB 2013
© 2013 AWHONN
Nursing for Women's Health
Volume 17, Issue 1, pages 42–51, February/March 2013
How to Cite
Merrill, L. (2013), Magnesium Sulfate During Anticipated Preterm Birth for Infant Neuroprotection. Nursing for Women's Health, 17: 42–51. doi: 10.1111/1751-486X.12005
- Issue published online: 11 FEB 2013
- Article first published online: 11 FEB 2013
- cerebral palsy;
- magnesium sulfate;
- preterm birth;
- preterm infants
Advances in medical care of preterm infants, including the widespread use of surfactant and antenatal steroids, and improvements in ventilation management, have increased the survival rates of some of the most vulnerable infants. Yet, the risk of neurologic impairment and long-term medical complications remains a concern. Recently, the use of magnesium sulfate during anticipated preterm birth has been identified as a potential treatment to reduce adverse neurologic outcomes among preterm infants. This article discusses the use of magnesium sulfate for anticipated preterm birth to reduce neurologic impairment in preterm infants, including current clinical practice guidelines and implications for nurses.